These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34288488)

  • 21. Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y
    Wang YH; Liu CX; Zhang YH; Yang YL; Zhao Y; Han L; Wang QQ; Xiao W; Hu QH; Ding ZH; Zhou MZ; Jiang C
    J Med Chem; 2024 Jul; 67(14):11989-12011. PubMed ID: 38959216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
    Mimoto T; Nojima S; Terashima K; Takaku H; Shintani M; Hayashi H
    Bioorg Med Chem; 2008 Feb; 16(3):1299-308. PubMed ID: 17981045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.
    Ulven T
    Front Endocrinol (Lausanne); 2012; 3():111. PubMed ID: 23060857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.
    Nair AG; Wong MK; Shu Y; Jiang Y; Jenh CH; Kim SH; Yang DY; Zeng Q; Shao Y; Zawacki LG; Duo J; McGuinness BF; Carroll CD; Hobbs DW; Shih NY; Rosenblum SB; Kozlowski JA
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1085-8. PubMed ID: 24486132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
    Milligan G; Stoddart LA; Smith NJ
    Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency.
    Corte JR; Yang W; Fang T; Wang Y; Osuna H; Lai A; Ewing WR; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Harper TW; Bozarth JM; Wu Y; Luettgen JM; Seiffert DA; Quan ML; Wexler RR; Lam PYS
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3833-3839. PubMed ID: 28687203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a biarylamide series of potent, state-dependent Na
    Schenkel LB; DiMauro EF; Nguyen HN; Chakka N; Du B; Foti RS; Guzman-Perez A; Jarosh M; La DS; Ligutti J; Milgram BC; Moyer BD; Peterson EA; Roberts J; Yu VL; Weiss MM
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3817-3824. PubMed ID: 28684121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.
    Sergeev E; Hansen AH; Pandey SK; MacKenzie AE; Hudson BD; Ulven T; Milligan G
    J Biol Chem; 2016 Jan; 291(1):303-17. PubMed ID: 26518871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
    Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and optimization of pyrazole amides as antagonists of CCR1.
    Harcken C; Sarko C; Mao C; Lord J; Raudenbush B; Razavi H; Liu P; Swinamer A; Disalvo D; Lee T; Lin S; Kukulka A; Grbic H; Patel M; Patel M; Fletcher K; Joseph D; White D; Amodeo L; Berg K; Brown M; Thomson DS
    Bioorg Med Chem Lett; 2019 Feb; 29(3):435-440. PubMed ID: 30455146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.
    Steeneck C; Gege C; Kinzel O; Albers M; Kleymann G; Schlüter T; Schulz A; Xue X; Cummings MD; Fourie AM; Leonard KA; Scott B; Edwards JP; Hoffmann T; Goldberg SD
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127174. PubMed ID: 32334912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Activity, and Docking Study of Novel Phenylthiazole-Carboxamido Acid Derivatives as FFA2 Agonists.
    Ma L; Wang T; Shi M; Fu P; Pei H; Ye H
    Chem Biol Drug Des; 2016 Jul; 88(1):26-37. PubMed ID: 26808470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and evaluation of Ca
    Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives.
    Astles PC; Brealey C; Brown TJ; Facchini V; Handscombe C; Harris NV; McCarthy C; McLay IM; Porter B; Roach AG; Sargent C; Smith C; Walsh RJ
    J Med Chem; 1998 Jul; 41(15):2732-44. PubMed ID: 9667964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors.
    Zhu HY; Desai J; Deng Y; Cooper A; Wang J; Shipps J; Samatar A; Carr D; Windsor W
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1627-9. PubMed ID: 25716905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
    Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
    Wang Y; Cai W; Zhang G; Yang T; Liu Q; Cheng Y; Zhou L; Ma Y; Cheng Z; Lu S; Zhao YG; Zhang W; Xiang Z; Wang S; Yang L; Wu Q; Orband-Miller LA; Xu Y; Zhang J; Gao R; Huxdorf M; Xiang JN; Zhong Z; Elliott JD; Leung S; Lin X
    Bioorg Med Chem; 2014 Jan; 22(2):692-702. PubMed ID: 24388993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and evaluation of Ca
    Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.
    Lee T; Schwandner R; Swaminath G; Weiszmann J; Cardozo M; Greenberg J; Jaeckel P; Ge H; Wang Y; Jiao X; Liu J; Kayser F; Tian H; Li Y
    Mol Pharmacol; 2008 Dec; 74(6):1599-609. PubMed ID: 18818303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.
    Brown ML; Aaron W; Austin RJ; Chong A; Huang T; Jiang B; Kaizerman JA; Lee G; Lucas BS; McMinn DL; Orf J; Rong M; Toteva MM; Xu G; Ye Q; Zhong W; Degraffenreid MR; Wickramasinghe D; Powers JP; Hungate R; Johnson MG
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5206-9. PubMed ID: 21840217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.